| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 109 |
| 1 | MYCOPHENOLATE MOFETIL | 100 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 96 |
| 3 | TACROLIMUS OINTMENT 0.1% | 96 |
| 4 | ADALIMUMAB | 66 |
| 5 | PREDNISONE | 56 |
| 6 | FINGOLIMOD HCL | 55 |
| 7 | PREDNISOLONE | 54 |
| 8 | PREDNISOLONE ORAL | 54 |
| 9 | PREDNISOLONE ORAL SOLUTION | 54 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYCERIN, LIDOCAINE, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0556 |
| 1 | ACONITUM NAPELLUS, BELLADONNA, CHAMOMILLA | 1 | 0.0400 |
| 2 | EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0333 |
| 3 | CLOTRIMAZOLE1% CLOTRIMAZOLE | 1 | 0.0182 |
| 4 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 1 | 0.0122 |
| 5 | HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 1 | 0.0111 |
| 6 | METHOXSALEN | 1 | 0.0079 |
| 7 | FOSAMPRENAVIR CALCIUM | 1 | 0.0076 |
| 8 | IMIQUIMOD | 15 | 0.0064 |
| 9 | CANTHARIDIN | 1 | 0.0055 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 8 | 0.0017 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 8 | 0.0014 |
| 3 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 4 | Calcitonin [EPC] | 4 | 0.0013 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 27 | 0.0013 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 16 | 0.0012 |
| 7 | Blood Viscosity Reducer [EPC] | 5 | 0.0012 |
| 8 | Interleukin-17 Receptor A Antagonist [EPC] | 2 | 0.0010 |
| 9 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 5 | 0.0010 |